Legal & General Group Plc lifted its stake in shares of Teleflex Incorporated (NYSE:TFX) by 5.8% in the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 90,332 shares of the medical technology company’s stock after buying an additional 4,929 shares during the quarter. Legal & General Group Plc owned approximately 0.20% of Teleflex worth $21,854,000 as of its most recent filing with the Securities and Exchange Commission.

Several other hedge funds also recently added to or reduced their stakes in TFX. Janus Henderson Group PLC grew its position in shares of Teleflex by 50,429.2% during the second quarter. Janus Henderson Group PLC now owns 1,816,020 shares of the medical technology company’s stock worth $377,296,000 after buying an additional 1,812,426 shares in the last quarter. Koch Industries Inc. grew its position in shares of Teleflex by 47,174.3% during the second quarter. Koch Industries Inc. now owns 959,669 shares of the medical technology company’s stock worth $955,000 after buying an additional 957,639 shares in the last quarter. American Century Companies Inc. grew its position in shares of Teleflex by 41.6% during the third quarter. American Century Companies Inc. now owns 1,187,909 shares of the medical technology company’s stock worth $287,438,000 after buying an additional 348,829 shares in the last quarter. Marshall Wace North America L.P. grew its position in shares of Teleflex by 137.4% during the second quarter. Marshall Wace North America L.P. now owns 518,462 shares of the medical technology company’s stock worth $107,840,000 after buying an additional 300,069 shares in the last quarter. Finally, Principal Financial Group Inc. grew its position in shares of Teleflex by 93.5% during the second quarter. Principal Financial Group Inc. now owns 610,398 shares of the medical technology company’s stock worth $126,816,000 after buying an additional 294,935 shares in the last quarter. 89.31% of the stock is owned by institutional investors and hedge funds.

In other news, Director Stephen K. M.D. Klasko sold 200 shares of the business’s stock in a transaction on Wednesday, November 1st. The shares were sold at an average price of $237.18, for a total transaction of $47,436.00. Following the completion of the transaction, the director now owns 8,080 shares of the company’s stock, valued at $1,916,414.40. The sale was disclosed in a filing with the SEC, which is accessible through this hyperlink. Also, CEO Benson Smith sold 2,000 shares of the business’s stock in a transaction on Monday, December 4th. The shares were sold at an average price of $258.10, for a total transaction of $516,200.00. Following the transaction, the chief executive officer now directly owns 76,634 shares of the company’s stock, valued at approximately $19,779,235.40. The disclosure for this sale can be found here. In the last ninety days, insiders sold 2,600 shares of company stock valued at $665,076. 2.39% of the stock is currently owned by corporate insiders.

A number of analysts have recently weighed in on TFX shares. Zacks Investment Research raised shares of Teleflex from a “hold” rating to a “buy” rating and set a $261.00 price target for the company in a research report on Tuesday, September 12th. Barclays reissued an “overweight” rating and set a $253.00 price target (up previously from $230.00) on shares of Teleflex in a research report on Tuesday, September 12th. Deutsche Bank reissued a “buy” rating and set a $251.00 price target (up previously from $238.00) on shares of Teleflex in a research report on Monday, September 18th. Stephens reissued a “buy” rating and set a $270.00 price target (up previously from $230.00) on shares of Teleflex in a research report on Monday, September 25th. Finally, Needham & Company LLC raised their price target on shares of Teleflex from $228.00 to $237.00 and gave the stock a “buy” rating in a research report on Tuesday, September 5th. One research analyst has rated the stock with a sell rating, five have issued a hold rating and six have issued a buy rating to the company. The company has a consensus rating of “Hold” and a consensus price target of $274.44.

Teleflex Incorporated (NYSE:TFX) traded up $1.68 during trading on Friday, reaching $252.76. 333,541 shares of the company’s stock were exchanged, compared to its average volume of 263,596. The firm has a market capitalization of $11,386.58, a P/E ratio of 31.24, a PEG ratio of 2.16 and a beta of 1.09. The company has a current ratio of 4.72, a quick ratio of 3.70 and a debt-to-equity ratio of 0.88. Teleflex Incorporated has a 1 year low of $154.32 and a 1 year high of $271.23.

Teleflex (NYSE:TFX) last released its quarterly earnings data on Thursday, November 2nd. The medical technology company reported $2.12 EPS for the quarter, topping analysts’ consensus estimates of $2.01 by $0.11. The firm had revenue of $534.70 million during the quarter, compared to the consensus estimate of $522.94 million. Teleflex had a net margin of 12.41% and a return on equity of 16.27%. The firm’s revenue was up 17.3% on a year-over-year basis. During the same quarter in the previous year, the company posted $1.80 earnings per share. research analysts predict that Teleflex Incorporated will post 8.35 EPS for the current year.

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, December 15th. Shareholders of record on Wednesday, November 15th will be issued a $0.34 dividend. This represents a $1.36 dividend on an annualized basis and a yield of 0.54%. The ex-dividend date is Tuesday, November 14th. Teleflex’s dividend payout ratio is presently 24.82%.

ILLEGAL ACTIVITY NOTICE: This story was originally posted by Watch List News and is the sole property of of Watch List News. If you are accessing this story on another publication, it was illegally stolen and republished in violation of U.S. and international copyright legislation. The correct version of this story can be read at https://www.watchlistnews.com/teleflex-incorporated-tfx-stake-increased-by-legal-general-group-plc/1755945.html.

Teleflex Company Profile

Teleflex Incorporated is a provider of medical technology products. The Company designs, develops, manufactures and supplies single-use medical devices used by hospitals and healthcare providers for diagnostic and therapeutic procedures in critical care and surgical applications. The Company operates through six segments: Vascular North America; Anesthesia North America; Surgical North America; Europe, the Middle East and Africa (EMEA); Asia, and Original Equipment Manufacturer (OEM).

Institutional Ownership by Quarter for Teleflex (NYSE:TFX)

Receive News & Ratings for Teleflex Incorporated Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teleflex Incorporated and related companies with Analyst Ratings Network's FREE daily email newsletter.